A trial to compare conventional drug therapy versus conventional drug therapy along with Pulmonary Rehabilitation in patients with Interstitial Lung Disease.
Not Applicable
- Conditions
- Health Condition 1: J848- Other specified interstitial pulmonary diseases
- Registration Number
- CTRI/2022/11/047192
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age above 18 years
ILD of any types (Idiopathic Interstitial Pneumonia, Autoimmune ILD, Sarcoidosis, other ILDs)
Exclusion Criteria
1. Other conditions which are contraindications for spirometry, according to American Thoracic Society guidelines.
2.Thoracic surgery in the previous six months or Patient with previous hospitalization in the last 3 weeks.
2. Patient not willing to do PR
3.Orthopaedic conditions which interfere with walking
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of conventional drug therapy along with a home-based, 12 -week pulmonary rehabilitation program on 6MWT performance capacity of ILD patients when compared to conventional drug therapy alone.Timepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method To study the effect of home-based, Pulmonary Rehabilitation on <br/ ><br>â?¢Pulmonary function, assessed by Spirometry <br/ ><br>â?¢Breathlessness, assessed by mMRC Dyspnoea Scale <br/ ><br>â?¢Respiratory function, assessed by St George Respiratory Questionnaire <br/ ><br>Timepoint: 12 weeks